B O O K - American College of Rheumatology

ACR/ARHP Poster Session B
950. Patient Global Impression of Change Results from a 1-Year
Open-Label Extension Study of Tapentadol Extended
Release in Patients with Chronic Osteoarthritis or Low Back
Pain. Bettyanne McCann 2 , Robert Lange 1 , Bertil Wagner 2 ,
Achim Steup 1 , Bernd Lange 1 and Mila Etrolpolski 2 , 1 Global
Development, Grünenthal GmbH, Aachen, Germany, 2 Johnson
& Johnson Pharmaceutical Research & Development, L.L.C.,
Raritan, NJ.
951. Racial/Ethnic Differences in Pain Sensation in Subjects with
or at Risk of Knee Osteoarthritis: Analysis of the Multicenter
Osteoarthritis (MOST) Study. Jasvinder Singh 1 , Tuhina Neogi 2 ,
David T. Felson 3 , James Torner 7 , Kristin Baker 4 , Michael C.
Nevitt 5 , Irina Tolstykh 5 and Cora E. Lewis 6 , 1 Birmigham VA
Medical Center and University of Alabama, Minneapolis, MN,
2
Boston Univ Schl of Med, Boston, MA, 3 Boston University
School of Medicine, Boston, MA, 4 Boston University School of
Medicine, 5 UCSF, San Francisco, CA, 6 University of Alabama,
7
University of Iowa.
952. The Importance of Methodological Quality for the Association
between Radiographic and Clinical Features of Hip and
Knee Osteoarthritis: A Systematic Review. M. B. Kinds 2 , E. P.
Vignon 5 , J. W. J. Bijlsma 4 , M. A. Viergever 1 , A. C. A. Marijnissen 4 ,
F. P. J. G. Lafeber 4 and P. M. J. Welsing 3 , 1 Image Sciences
Institute, University Medical Center Utrecht, The Netherlands,
2
Rheumatology & Clinical Immunology, Image Sciences
Institute, University Medical Center Utrecht, The Netherlands,
3
Rheumatology & Clinical Immunology, Julius Center for Health
Sciences & Primary Care, University Medical Center Utrecht, The
Netherlands, 4 Rheumatology & Clinical Immunology, University
Medical Center Utrecht, The Netherlands, 5 Rheumatology,
University Hospital Lyon-Sud Pierre-Benite, France.
953. Time to Onset of Gastrointestinal Adverse Events of
Naproxcinod vs. Naproxen and Placebo in Patients with
Osteoarthritis. Byron Cryer 2 , Angel Lanas 1 , Rosanna Fleming 4 ,
Fabrizio Dolphi 3 , Diana Aguirre 3 and Brigitte Duquesroix 3 ,
1
Aragon Health Sciences Institute, University of Zaragoza,
2
Department of Veterans Affairs Medical Center, 3 NicOx SA,
4
NicOx, Inc.
954. Topical Diclofenac Solution (PENNSAID®) Compared with Oral
Diclofenac in Osteoarthritis of the Knee: Pooled Analysis from
2 Controlled Clinical Trials. Sanford H. Roth 1 and Philip Fuller 2 ,
1
Arizona Research and Education, Arthritis Research Laboratory,
Arizona State University, Phoenix, AZ, 2 Covidien.
955. Topical Diclofenac Solution with the Absorption Enhancer
Dimethyl Sulfoxide (PENNSAID®) for the Treatment of
Osteoarthritis of the Knee: Integrated Summary of Safety.
Sanford H. Roth 1 and Philip Fuller 2 , 1 Arizona Research and
Education, Arthritis Research Laboratory, Arizona State
University, Phoenix, AZ, 2 Covidien.
Osteoporosis and Metabolic Bone Disease: Clinical Aspects and
Pathogenesis
956. Adenosine A2A Antagonist ZM241385 Increases Osteoblast
Differentiation and Function In Vitro. Louisa Ziglar 2 and Bruce
N. Cronstein 1 , 1 New York Univ Med Ctr, New York, NY, 2 NYU
Medical Center, New York, NY.
957. Algorithm for Using a Bone Formation Marker PINP To
Monitor the Response to Teriparatide (TPTD) in Patients with
Glucocorticoid-Induced Osteoporosis (GIO). Nancy E. Lane 2 ,
Kyoungah See 1 , Margaret Warner 1 and John H. Krege 1 , 1 Eli Lilly,
Indianapolis, IN, 2 Univ of California at Davis, Hillsborough, CA.
958. Anti-Hypertensive Therapy and Bone Mineral Density: Analysis
in a Population-Based U.S. Sample. Mitsuyo Kinjo 3 , Soko
Setoguchi 1 and Daniel Hal Solomon 2 , 1 Brigham and Women’s
Hospital, 2 Brigham and Womens Hospital, Boston, MA,
3
Okinawa Chubu Hospital, Japan.
959. Bone Density Following Long-Duration Spaceflight and
Recovery. Shreyasee Amin 1 , Sara Achenbach 1 , Elizabeth
Atkinson 1 , L. Joseph Melton 1 , Sundeep Khosla 1 and Jean
Sibonga 2 , 1 Mayo Clinic, 2 NASA-Johnson Space Center.
960. Bone Geometry Parameters among Black and White Women
with SLE. Jimmy D. Alele 2 , Diane L. Kamen 2 , Kelly J. Hunt 2 , Gary
S. Gilkeson 1 and Rosalind Ramsey-Goldman 3 , 1 Med Univ of
South Carolina, Charleston, SC, 2 Medical University of South
Carolina, Charleston, SC, 3 Northwestern University, Chicago, IL.
961. Cardiovascular Disease Is Associated with Increased Bone Loss
and Fracture Risk: A Systematic Review of the Association
between Cardiovascular Disease and Osteoporosis. Debby den
Uyl 2 , Mike T. Nurmohamed 1 , Lilian H. D. van Tuyl 2 , Hennie G.
Raterman 2 and Willem F. Lems 2 , 1 Department Rheumatology/
Jan van Breemen Institute, Amsterdam, The Netherlands,
2
Department Rheumatology/VU University Medical Centre,
Amsterdam, The Netherlands.
962. Cholecalciferol High Dose Supplementation Should Be
Preferred in Rheumatic Patients Independently to the
Presence of an Autoimmune Disease. Mattia Bellan 3 , Pier
Paolo Sainaghi 1 and Mario Pirisi 2 , 1 Immuno-Rheumatology
Outpatient Unit, DMCS, “A. Avogadro” University and IRCAD
(Interdisciplinary Reseach Center of Autoimmune Diseases),
Novara, Novara, Italy, 2 Immuno-Rheumatology Outpatient Unit,
DMCS, “A. Avogadro” University and IRCAD (Interdisciplinary
Reseach Center of Autoimmune Diseases), Novara, Italy,
3
Immuno-Rheumatology Outpatient Unit, DMCS, “A. Avogadro”
University, Novara, Italy.
963. Differences in the Observed Rate of Hip Fracture in Male and
Female Patients Diagnosed with Osteoarthritis or Ankylosing
Spondylitis Compared with the Expected Based on the
General Population Seeking Health Care. Martin Englund 2 ,
Jonas Franklin 3 and Ingemar F. Petersson 1 , 1 Lund University
Hosp, Lund, Sweden, 2 Musculoskeletal Sciences, Department
of Orthopedics, Clinical Sciences Lund, Lund University, Lund,
Sweden, 3 University Hospital, Akureyri, Iceland.
964. Effect of Oral Ibandronate on Bone Microarchitecture in
Women with Osteopenia – A Randomized Placebo-Controlled
Trial. Roland Chapurlat 2 , Michel Laroche 4 , Thierry Thomas 1 ,
Stéphanie Rouanet 5 , Pierre D. Delmas 2 and Marie-Christine de
Vernejoul 3 , 1 CHU St Etienne, Saint Etienne, France, 2 INSERM
U831, Université de Lyon, Hôpital E Herriot, Lyon, France,
3
Lariboisière Hospital, Paris, France, 4 Pôle Institut Locomoteur
Hôpital Purpan, Toulouse, France, 5 Roche France, Neuilly,
France.
965. Effects of Glucocorticoid on Osteocyte Autophagy In Vivo. Wei
Yao 1 , Junjing Jia 1 , Weiwei Dai 1 , Min Guan 1 , Lynda Bonewald 3 and
Nancy E. Lane 2 , 1 UC Davis Medical Center, 2 Univ of California at
Davis, Hillsborough, CA, 3 Univ. of Missouri at Kansas City, School
of Dentistry, Dept. of Oral Biology, Kansas City, MO.
966. Fracture Epidemiology among a Cohort of HIV-Infected Adults
in the UK: An Epidemiologic Study. Karen Walker-Bone 1 ,
Reshad Malik 2 , Martin Fisher 2 , Yvonne Gilleece 2 and Amanda
Samarawickrama 2 , 1 Brighton& Sussex Medical School, Brighton,
East Sussex, United Kingdom, 2 Brighton & Sussex University
Hospitals NHS Trust.
206
2010 Program Book